Prostate Cancer Study Proves Drug Delays Disease Progression
(TORONTO, Canada — Jan. 24, 2012) — For men diagnosed with low-risk, localized prostate cancer, being treated with the drug dutasteride (“Avodart”) delays disease progression and initiating active treatment, and also reduces anxiety, show the results of a three-year international clinical trial led by Dr. Neil Fleshner, Head of the Division of Urology, University Health Network (UHN). Fulll story here: www.uhn.ca